Clinical Trial Results:
A 39-week randomized, double-blind, parallel group, multicenter study to evaluate the effect of fixed dose Stalevo 100 (t.i.d.) vs. immediate release carbidopa/levodopa (t.i.d.) in Parkinson's disease patients requiring levodopa.
Summary
|
|
EudraCT number |
2005-001032-72 |
Trial protocol |
PT CZ IT |
Global completion date |
25 Sep 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
10 May 2017
|
First version publication date |
06 Jan 2017
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
CELC200A2305 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.